Joe
07-09-2007, 05:40 AM
A recent meta-analysis of five major breast cancer trials has confirmed that combination treatment with the antibody trastuzumab and chemotherapy improves survival in women with operable HER-2 positive breast cancer.
More... (http://www.news-medical.net/?id=27230)
More... (http://www.news-medical.net/?id=27230)